Poseida Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Poseida Therapeutics

11/08/2022 22:00

* Poseida Therapeutics Inc  PSTX.OQ  reported a quarterly
adjusted
loss of 69 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 76 cents per share.
    * Revenue was $2.70 million​; analysts expected $1.06
million. 
    * Poseida Therapeutics Inc's reported EPS for the quarter
was a
loss of 69 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Poseida Therapeutics Inc shares had risen by 44.6% this
quarter and lost 45.2% so far this year.
    * The company reported a quarterly loss of $43.04 million.
    * Wall Street's median 12-month price target for Poseida
Therapeutics Inc is $16.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 08:59 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.76          -0.69          Beat
 Mar. 31 2022      -0.66          -0.93          Missed
 Dec. 31 2021      -0.35          0.02           Beat
 Sep. 30 2021      -0.74          -0.68          Beat